Is tendinitis an inflammatory disease initiated and driven by pro-inflammatory cytokines such as interleukin 1ß?

Histology and Histopathology

Volumn 28, Issue 8, 2013, Pages 955-964

  Mobasheri, A ^a   Shakibaei, M ^b  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

Interleukin 1 (IL 1 ); Pro inflammatory Cytokine; Tendon; Tendonitis

Indexed keywords

COLLAGEN; CYTOKINE; INTERLEUKIN 1BETA; QUINOLONE DERIVATIVE;

ACHILLES TENDON; ANIMAL; APOPTOSIS; CHEMISTRY; EXTRACELLULAR MATRIX; HUMAN; INFLAMMATION; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; RAT; REVIEW; TENDINITIS; TENDON; ULTRASTRUCTURE;

ACHILLES TENDON; ANIMALS; APOPTOSIS; COLLAGEN; CYTOKINES; EXTRACELLULAR MATRIX; FLUOROQUINOLONES; HUMANS; INFLAMMATION; INTERLEUKIN-1BETA; RATS; TENDINOPATHY; TENDONS;

EID: 84880445957     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (72)

1. Amiel D., Frank C., Harwood F., Fronek J. and Akeson W. (1984). Tendons and ligaments: a morphological and biochemical comparison. J. Orthop. Res. 1, 257-265.
2. Anitua E., Andia I., Sanchez M., Azofra J., del Mar Zalduendo M., de la Fuente M., Nurden P. and Nurden A.T. (2005). Autologous preparations rich in growth factors promote proliferation and induce VEGF and HGF production by human tendon cells in culture. J. Orthop. Res. 23, 281-286.
3. Battery L. and Maffulli N. (2011). Inflammation in overuse tendon injuries. Sports Med. Arthrosc. 19, 213-217.
4. Bernard-Beaubois K., Hecquet C., Houcine O., Hayem G. and Adolphe M. (1997). Culture and characterization of juvenile rabbit tenocytes. Cell Biol. Toxicol. 13, 103-113.
5. Beynnon B.D. and Johnson R.J. (1996). Anterior cruciate ligament injury rehabilitation in athletes. Biomechanical considerations. Sports Med. 22, 54-64.
6. Buckwalter J.A. (1996). Effects of early motion on healing of musculoskeletal tissues. Hand Clin. 12, 13-24.
7. Bunning R.A., Richardson H.J., Crawford A., Skjodt H., Hughes D., Evans D.B., Gowen M., Dobson P.R., Brown B.L. and Russell R.G. (1986). The effect of interleukin-1 on connective tissue metabolism and its relevance to arthritis. Agents Actions Suppl. 18, 131-152.
8. Burner T.W. and Rosenthal A.K. (2009). Diabetes and rheumatic diseases. Curr. Opin. Rheumatol. 21, 50-54.
9. Corps A.N., Robinson A.H., Harrall R.L., Avery N.C., Curry V.A., Hazleman B.L. and Riley G.P. (2012). Changes in matrix protein biochemistry and the expression of mRNA encoding matrix proteins and metalloproteinases in posterior tibialis tendinopathy. Ann. Rheum. Dis. 71, 746-752.
10. Cserjesi P., Brown D., Ligon K.L., Lyons G.E., Copeland N.G., Gilbert D.J., Jenkins N.A. and Olson E.N. (1995). Scleraxis: a basic helixloop-helix protein that prefigures skeletal formation during mouse embryogenesis. Development 121, 1099-1110.
11. Del Buono A., Battery L., Denaro V., Maccauro G. and Maffulli N. (2011). Tendinopathy and inflammation: some truths. Int. J. Immunopathol. Pharmacol. 24, 45-50.
12. Dinarello C.A. (1989). Interleukin-1 and its biologically related cytokines. Adv. Immunol. 44, 153-205.
13. Dinarello C.A. (2011). A clinical perspective of IL-1beta as the gatekeeper of inflammation. Eur. J. Immunol. 41, 1203-1217.
14. Dinarello C.A. and Savage N. (1989). Interleukin-1 and its receptor. Crit. Rev. Immunol. 9, 1-20.
15. Ding G.J., Fischer P.A., Boltz R.C., Schmidt J.A., Colaianne J.J., Gough A., Rubin R.A. and Miller D.K. (1998). Characterization and quantitation of NF-kappaB nuclear translocation induced by interleukin-1 and tumor necrosis factor-alpha. Development and use of a high capacity fluorescence cytometric system. J. Biol. Chem. 273, 28897-28905.
16. Docheva D., Hunziker E.B., Fassler R. and Brandau O. (2005). Tenomodulin is necessary for tenocyte proliferation and tendon maturation. Mol. Cell Biol. 25, 699-705.
17. Favata M., Beredjiklian P.K., Zgonis M.H., Beason D.P., Crombleholme T.M., Jawad A.F. and Soslowsky L.J. (2006). Regenerative properties of fetal sheep tendon are not adversely affected by transplantation into an adult environment. J. Orthop. Res. 24, 2124-2132.
18. Fedorczyk J.M., Barr A.E., Rani S., Gao H.G., Amin M., Amin S., Litvin J. and Barbe M.F. (2010). Exposure-dependent increases in IL-1beta, substance P, CTGF, and tendinosis in flexor digitorum tendons with upper extremity repetitive strain injury. J. Orthop. Res. 28, 298-307.
19. Feldmann M., Brennan F.M. and Maini R.N. (1996). Role of cytokines in rheumatoid arthritis. Annu. Rev. Immunol. 14, 397-440.
20. Funck-Brentano T. and Cohen-Solal M. (2011). Crosstalk between cartilage and bone: When bone cytokines matter. Cytokine Growth Factor Rev. 22, 91-97.
21. Gaida J.E., Ashe M.C., Bass S.L. and Cook J.L. (2009). Is adiposity an under-recognized risk factor for tendinopathy? A systematic review. Arthritis Rheum. 61, 840-849.
22. Gray R.G. and Gottlieb N.L. (1976). Rheumatic disorders associated with diabetes mellitus: literature review. Semin. Arthritis Rheum. 6, 19-34.
23. Herrmann H., Dessau W., Fessler L.I. and von der Mark K. (1980). Synthesis of types I, III and AB2 collagen by chick tendon fibroblasts in vitro. Eur. J. Biochem. 105, 63-74.
24. Holmes G.B. and Lin J. (2006). Etiologic factors associated with symptomatic achilles tendinopathy. Foot Ankle Int. 27, 952-959.
25. Jarvinen T.A., Jarvinen T.L., Kannus P., Jozsa L. and Jarvinen M. (2004). Collagen fibres of the spontaneously ruptured human tendons display decreased thickness and crimp angle. J. Orthop. Res. 22, 1303-1309.
26. Jarvinen T.A., Kannus P., Maffulli N. and Khan K.M. (2005). Achilles tendon disorders: etiology and epidemiology. Foot Ankle Clin. 10, 255-266.
27. Jelinsky S.A., Rodeo S.A., Li J., Gulotta L.V., Archambault J.M. and Seeherman H.J. (2011). Regulation of gene expression in human tendinopathy. BMC Musculoskelet. Disord. 12, 86.
28. John T., Lodka D., Kohl B., Ertel W., Jammrath J., Conrad C., Stoll C., Busch C. and Schulze-Tanzil G. (2010). Effect of pro-inflammatory and immunoregulatory cytokines on human tenocytes. J. Orthop. Res. 28, 1071-1077.
29. Kahn M.F. and Hayem G. (1997). Tendons and fluoroquinolones. Unresolved issues. Rev Rhum Engl Ed. 64, 437-439.
30. Kannus P. (2000). Structure of the tendon connective tissue. Scand. J. Med. Sci Sports. 10, 312-320.
31. Kapoor M., Martel-Pelletier J., Lajeunesse D., Pelletier J.P. and Fahmi H. (2011). Role of proinflammatory cytokines in the pathophysiology of osteoarthritis. Nat. Rev. Rheumatol. 7, 33-42.
32. Kastelic J., Galeski A. and Baer E. (1978). The multicomposite structure of tendon. Connect. Tissue Res. 6, 11-23.
33. Khaliq Y. and Zhanel G.G. (2003). Fluoroquinolone-associated tendinopathy: a critical review of the literature. Clin. Infect. Dis. 36, 1404-1410.
34. Khan R.J., Fick D., Keogh A., Crawford J., Brammar T. and Parker M. (2005). Treatment of acute achilles tendon ruptures. A metaanalysis of randomized, controlled trials. J. Bone Joint Surg. Am. 87, 2202-2210.
35. Ko J.Y., Wang F.S., Huang H.Y., Wang C.J., Tseng S.L. and Hsu C. (2008). Increased IL-1beta expression and myofibroblast recruitment in subacromial bursa is associated with rotator cuff lesions with shoulder stiffness. J. Orthop. Res. 26, 1090-1097.
36. Koob T.J. (2002). Biomimetic approaches to tendon repair. Comp. Biochem. Physiol. A Mol. Integr. Physiol. 133, 1171-1192.
37. Lian O.B., Engebretsen L. and Bahr R. (2005). Prevalence of jumper's knee among elite athletes from different sports: a cross-sectional study. Am. J. Sports Med. 33, 561-567.
38. Liles W.C. and Van Voorhis W.C. (1995). Review: nomenclature and biologic significance of cytokines involved in inflammation and the host immune response. J. Infect. Dis. 172, 1573-1580.
39. Loeser R.F. (2011). Aging and osteoarthritis. Curr. Opin. Rheumatol. 23, 492-496.
40. Maini R.N. and Taylor P.C. (2000). Anti-cytokine therapy for rheumatoid arthritis. Annu. Rev. Med. 51, 207-229.
41. Marcu K.B., Otero M., Olivotto E., Borzi R.M. and Goldring M.B. (2010). NF-kappaB signaling: multiple angles to target OA. Curr. Drug Targets. 11, 599-613.
42. Miyatake S., Tohyama H., Kondo E., Katsura T., Onodera S. and Yasuda K. (2008). Local administration of interleukin-1 receptor antagonist inhibits deterioration of mechanical properties of the stress-shielded patellar tendon. J. Biomech. 41, 884-889.
43. Molloy T.J., Kemp M.W., Wang Y. and Murrell G.A. (2006). Microarray analysis of the tendinopathic rat supraspinatus tendon: glutamate signaling and its potential role in tendon degeneration. J. Appl. Physiol. 101, 1702-1709.
44. Montgomery R.D. (1989). Healing of muscle, ligaments, and tendons. Semin. Vet. Med. Surg. (Small Anim). 4, 304-311.
45. Ochiai N., Matsui T., Miyaji N., Merklin R.J. and Hunter J.M. (1979). Vascular anatomy of flexor tendons. I. Vincular system and blood supply of the profundus tendon in the digital sheath. J. Hand Surg. Am. 4, 321-330.
46. Pelletier J.P., Roughley P.J., DiBattista J.A., McCollum R. and Martel-Pelletier J. (1991). Are cytokines involved in osteoarthritic pathophysiology? Semin. Arthritis Rheum. 20, 12-25.
47. Pelletier J.P., DiBattista J.A., Roughley P., McCollum R. and Martel-Pelletier J. (1993). Cytokines and inflammation in cartilage degradation. Rheum. Dis. Clin. North Am. 19, 545-568.
48. Qi J., Fox A.M., Alexopoulos L.G., Chi L., Bynum D., Guilak F. and Banes A.J. (2006). IL-1beta decreases the elastic modulus of human tenocytes. J. Appl. Physiol. 101, 189-195.
49. Raspanti M., Manelli A., Franchi M. and Ruggeri A. (2005). The 3D structure of crimps in the rat Achilles tendon. Matrix Biol. 24, 503-507.
50. Riley G. (2004). The pathogenesis of tendinopathy. A molecular perspective. Rheumatology (Oxford). 43, 131-142.
51. Riley G. (2008). Tendinopathy--from basic science to treatment. Nat. Clin. Pract. Rheumatol. 4, 82-89.
52. Rosenbloom A.L. (1984). Skeletal and joint manifestations of childhood diabetes. Pediatr. Clin. North Am. 31, 569-589.
53. Rosenbloom A.L. and Silverstein J.H. (1996). Connective tissue and joint disease in diabetes mellitus. Endocrinol. Metab. Clin. North Am. 25, 473-483.
54. Samiric T., Parkinson J., Ilic M.Z., Cook J., Feller J.A. and Handley C.J. (2009). Changes in the composition of the extracellular matrix in patellar tendinopathy. Matrix Biol. 28, 230-236.
55. Schulze-Tanzil G., Mobasheri A., Clegg P.D., Sendzik J., John T. and Shakibaei M. (2004). Cultivation of human tenocytes in high-density culture. Histochem. Cell Biol. 122, 219-228.
56. Schwarz R.I. and Bissell M.J. (1977). Dependence of the differentiated state on the cellular environment: modulation of collagen synthesis in tendon cells. Proc. Natl. Acad. Sci. USA 74, 4453-4457.
57. Schweitzer R., Chyung J.H., Murtaugh L.C., Brent A.E., Rosen V., Olson E.N., Lassar A. and Tabin C.J. (2001). Analysis of the tendon cell fate using Scleraxis, a specific marker for tendons and ligaments. Development 128, 3855-3866.
58. Scott A., Khan K.M. and Duronio V. (2005). IGF-I activates PKB and prevents anoxic apoptosis in Achilles tendon cells. J. Orthop. Res. 23, 1219-1225.
59. Sendzik J., Shakibaei M., Schafer-Korting M. and Stahlmann R. (2005). Fluoroquinolones cause changes in extracellular matrix, signalling proteins, metalloproteinases and caspase-3 in cultured human tendon cells. Toxicology 212, 24-36.
60. Sharma P. and Maffulli N. (2005). Tendon injury and tendinopathy: healing and repair. J. Bone Joint Surg. Am. 87, 187-202.
61. Sharma P. and Maffulli N. (2006). Biology of tendon injury: healing, modeling and remodeling. J. Musculoskelet. Neuronal Interact. 6, 181-190.
62. Shukunami C., Oshima Y. and Hiraki Y. (2001). Molecular cloning of tenomodulin, a novel chondromodulin-I related gene. Biochem. Biophys. Res. Commun. 280, 1323-1327.
63. Tak P.P., Gerlag D.M., Aupperle K.R., van de Geest D.A., Overbeek M., Bennett B.L., Boyle D.L., Manning A.M. and Firestein G.S. (2001). Inhibitor of nuclear factor kappaB kinase beta is a key regulator of synovial inflammation. Arthritis Rheum. 44, 1897-1907.
64. Tang J.B., Xu Y. and Wang X.T. (2004). Tendon healing in vitro: activation of NIK, IKKalpha, IKKbeta, and NF-kappaB genes in signal pathway and proliferation of tenocytes. Plast. Reconstr. Surg. 113, 1703-1711.
65. Thampatty B.P., Li H., Im H.J. and Wang J.H. (2007). EP4 receptor regulates collagen type-I, MMP-1, and MMP-3 gene expression in human tendon fibroblasts in response to IL-1 beta treatment. Gene 386, 154-161.
66. Tsuzaki M., Guyton G., Garrett W., Archambault J.M., Herzog W., Almekinders L., Bynum D., Yang X. and Banes A.J. (2003). IL-1 beta induces COX2, MMP-1,-3 and-13, ADAMTS-4, IL-1 beta and IL-6 in human tendon cells. J. Orthop. Res. 21, 256-264.
67. Uchida H., Tohyama H., Nagashima K., Ohba Y., Matsumoto H., Toyama Y. and Yasuda K. (2005). Stress deprivation simultaneously induces over-expression of interleukin-1beta, tumor necrosis factoralpha, and transforming growth factor-beta in fibroblasts and mechanical deterioration of the tissue in the patellar tendon. J. Biomech. 38, 791-798.
68. van der Linden P.D., van de Lei J., Nab H.W., Knol A. and Stricker B.H. (1999). Achilles tendinitis associated with fluoroquinolones. Br. J. Clin. Pharmacol. 48, 433-437.
69. van der Linden P.D., van Puijenbroek E.P., Feenstra J., Veld B.A., Sturkenboom M.C., Herings R.M., Leufkens H.G. and Stricker B.H. (2001). Tendon disorders attributed to fluoroquinolones: a study on 42 spontaneous reports in the period 1988 to 1998. Arthritis Rheum. 45, 235-239.
70. Wang W., Tang X., Zhang J., Yan X. and Ma Y. (2010). Complete stress shielding of the Achilles tendon: ultrastructure and level of interleukin-1 and TGF-beta. Orthopedics 33, 810.
71. Wong J., Barrass V. and Maffulli N. (2002). Quantitative review of operative and nonoperative management of achilles tendon ruptures. Am. J. Sports Med. 30, 565-575.
72. Yao L., Bestwick C.S., Bestwick L.A., Maffulli N. and Aspden R.M. (2006). Phenotypic drift in human tenocyte culture. Tissue Eng. 12, 1843-1849.